Factors associated with severe infection in rheumatoid arthritis patients: lessons learned from the COVID-19 pandemic

Aya Embaby,Lobna A Maged,Hoda M Abdel-Hamid,Khaled T El Hadidi,Lobna A. Maged,Hoda M. Abdel-Hamid,Khaled T. El Hadidi
DOI: https://doi.org/10.1007/s15010-024-02187-z
2024-02-22
Infection
Abstract:Purpose This aimed to identify the factors associated with severe/critical coronavirus disease 2019 (COVID-19) infection in rheumatoid arthritis (RA) patients. Methods Two-hundred RA patients diagnosed according to the American College of Rheumatology/ European League Against Rheumatism (ACR/EULAR) classification criteria with proven COVID-19 infection were recruited and categorized according to the world health organization (WHO) COVID-19 severity grading into 2 groups: patients with mild/moderate COVID-19 ( n = 164) and patients with severe/critical COVID-19 ( n = 36). Comparison between both groups was done to identify the risk factors associated with severe/critical infection. Incidence of RA disease activity flare defined as increase in clinical disease activity index (CDAI) more than 10 points following infection was calculated. Results Multivariate analysis identified history of previous serious infection, age > 60 years, and diabetes as factors positively associated, whereas COVID-19 vaccination was negatively associated with severe/critical infection. Following COVID-19 infection, the number of patients with severe/critical COVID-19 who had high RA disease activity and the incidence of flares was significantly higher in comparison to patients with mild/moderate COVID-19 ( P < 0.001 and 0.003; respectively). Conclusion Age > 60 years, diabetes, and history of previous serious infections are risk factors for severe/critical COVID-19, while vaccination has a protective role in RA patients. Infection particularly when severe is associated with risk of disease flare.
infectious diseases
What problem does this paper attempt to address?
This paper aims to explore the factors associated with severe Coronavirus Disease 2019 (COVID - 19) infection in patients with rheumatoid arthritis (RA). Specifically, the research objective is to identify which factors are related to severe or critical COVID - 19 infection in RA patients. By analyzing the data of 200 RA patients diagnosed with COVID - 19, the researchers divided these patients into the mild/moderate group (164 people) and the severe/critical group (36 people) according to the World Health Organization (WHO) COVID - 19 severity classification criteria, and compared the differences between these two groups to determine the risk factors leading to severe infection. In addition, the study also evaluated the incidence of exacerbated RA disease activity (defined as an increase in the Clinical Disease Activity Index (CDAI) of more than 10 points) after COVID - 19 infection.